Celgene (CELG) Tops Q1 EPS by 4c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Celgene (CELG) Tops Q1 EPS by 4c; Raises Outlook

Celgene Reports First Quarter 2017 Operating and Financial Results

April 27, 2017 7:27 AM EDT

- Net Product Sales of $2.95B in Q1:17; Increased 18% Y/Y

- REVLIMID® Net Product Sales of $1.9B in Q1:17; Increased 20% Y/Y

- Raising 2017 EPS Guidance

- Positive phase II STEPSTONE data with ozanimod in Crohns disease; Phase III trial initiation planned by year-end

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported net product sales of $2,950 million for the first quarter of 2017, an 18 percent increase from the same period in 2016. Net product sales... More